ZGC Haidian Bio-Intelligent innovation Park

Overview

ZGC Haidian Bio-Intelligent innovation Park is located in the Zhongguancun Yongfeng High-Tech Industrial Base, covering an area of 62,100 square meters with a total construction area of 118,500 square meters. The park is committed to transforming high-tech innovations into industrial applications.

The Park specializes in pharmaceutical and health industry, hosting 16 enterprises in total. Among them, it boasts 1 unicorn and 1 gazelle company, reflecting its dynamic ecosystem for high-growth innovators. The park has achieved an annual revenue of 890 million RMB, supported by substantial R&D investment of 385 million RMB, which underscores its commitment to technological advancement. This focus on innovation is further evidenced by 262 patent applications for inventions, highlighting the park' s role as a key driver in biomedicine and intelligent manufacturing.

Industry Agglomeration

The park primarily focuses on biopharmaceutical research and experimental development as well as pilot-scale production. It concentrates on cutting-edge technology areas such as proteins and peptides, cell and gene therapy, antibody drugs, and advanced medical devices. To date, it has attracted more than 16 high-precision medical and health enterprises, covering innovative drug R&D and production.

Resources and Services

ZGC Haidian Bio-Intelligent innovation Park is equipped with a variety of service platforms, including incubation platforms, experimental animal facilities, common technology platforms, and AI computational biology/medicine platforms. The park owns biomedical instruments and equipment valued at 40 million yuan, including advanced analytical equipment like nuclear magnetic resonance spectrometers and high-resolution mass spectrometers, which support the efficient R&D of innovative drugs. Through digital technology, the park has achieved full-platform IoT deployment to enhance the efficiency of technology transfer. Additionally, it collaborates with third parties to establish SPF-level experimental animal facilities, providing professional R&D support and technical services to enterprises